Loading...
Market
What will be the outcome of H.R.3391 in the Senate by December 31, 2025?
2
Republican•House•Senate•Democrat•Chuck Schumer•Republicans•Democrats•Hakeem Jeffries•Elon Musk•Senate Democrats
Resolution / Starting Odds
Passed and signed into law • 25%
Passed but not signed into law • 25%
Not passed • 25%
No vote held • 25%
Official records from the U.S. Senate or a reputable news source
Story
Senate Democrats, Led by Chuck Schumer, Stall H.R.3391 Pediatric Cancer Research Funding Passed by Republican-led House
Dec 20, 2024, 06:15 PM
A $190 million funding bill for pediatric cancer research, known as H.R.3391 - the Gabriella Miller Kids First Research Act 2.0, was passed by the Republican-led House on March 5, 2024, with a vote of 384-4. The bill was received in the Senate on March 6, 2024, but has been stalled in the Democrat-controlled Senate. Senate Majority Leader Chuck Schumer has not brought the bill to a vote, leading to accusations from Republicans that Democrats are using it as a bargaining chip. Democrats, including House Minority Leader Hakeem Jeffries, have criticized Republicans for cutting the funding from a recent continuing resolution (CR), attributing the decision to influence from Elon Musk. However, the bipartisan standalone bill for pediatric cancer research has been held up in the Senate since its passage in the House, with no action taken by Senate Democrats.
View original story
Similar markets
Passed without amendments • 25%
Passed with amendments • 25%
Not passed • 25%
No vote taken • 25%
Passes • 33%
Fails • 33%
Delayed • 34%
Passed without amendments • 25%
Passed with amendments • 25%
Rejected • 25%
No vote by deadline • 25%
Passed without amendments • 25%
Passed with amendments • 25%
Rejected • 25%
Still under consideration • 25%
Pass with majority Republican support • 25%
Pass with bipartisan support • 25%
Fail with majority Republican support • 25%
Fail with bipartisan opposition • 25%
Tied vote • 25%
Other • 25%
Pass with majority • 33%
Fail to pass • 33%
Filibustered • 34%
Passed with majority Republican support • 25%
Passed with majority Democratic support • 25%
Failed with majority Republican opposition • 25%
Failed with majority Democratic opposition • 25%
Passes with majority • 33%
Fails to pass • 33%
Delayed without vote • 34%
